[1] Cruz-Jentoft AJ,Bahat G,Bauer J,et al. Sarcopenia:revised European consensus on definition and diagnosis.Age Ageing,2019,48(1):16-31.
[2] Tantai X, Liu Y, Yeo YH,et al.Effect of sarcopenia on survival in patients with cirrhosis:A systematic review and meta-analysis.J Hepatol,2021,S0168-8278(21):02174-02177.
[3] Nardelli S,Lattanzi,Merli M,et al.Muscle alterations are associated with minimal and overt hepatic encephalopathy in patients with liver cirrhosis.Hepatology,2019,70(5):1704-1713.
[4] Bhanji RA,Moctezuma-Velazquez C,Duarte-Rojo A,et al. Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis.Hepatol Int,2018,12(4):377-386.
[5] 刘钰懿,陈东风,颜綦先.肝硬化肌少症的发病机制与诊疗现状.临床肝胆病杂志,2022,38(1): 191-195.
[6] Thandassery RB,Montano-Loza AJ. Role of nutrition and muscle in cirrhosis.Curr Treat Options Gastroenterol,2016,14(2):257-273.
[7] Lai JC,Tandon P,Bernal W,et al. Malnutrition,Frailty,and Sarcopenia in Patients With Cirrhosis:2021 Practice Guidance by the American Association for the Study of Liver Diseases.Hepatology,2021,74(3):1611-1644.
[8] 张军昌,王永刚,林芳,等.肝性脑病发病机制新进展.中国肝脏病杂志(电子版),2019,11(01):6-11.
[9] Tandon Puneeta,Montano-Loza Aldo J,Lai Jennifer C, et al. Sarcopenia and frailty in decompensated cirrhosis.J Hepatol, 2021,15(07):147-162.
[10] Miwa T,Hanai T,Nishimura K,et al.Handgrip strength stratifies the risk of covert and overt hepatic encephalopathy in patients with cirrhosis.JPEN J Parenter Enteral Nutre,2022,46(4):858-866.
[11] Hanai T,Shiraki M,Watanabe S,et al. Sarcopenia predicts minimal hepatic encephalopathy in patients with liver cirrhosis.Hepatol Res,2017,47(13):1359-1367.
[12] Lattanzi BD,Ambrosio D,Merli M. Hepatic encephalopathy and sarcopenia:two faces of the same metabolic alteration.J Clin Exp Hepatol,2019,9(1):125-130.
[13] Gioia Stefania,Merli Manuela,Nardelli Silvia,et al.The modification of quantity and quality of muscle mass improves the cognitive impairment after TIPS.Liver Int,2019,39(5):871-877.
[14] Tateyama M,Naoe H,Tanaka M,et al.Loss of skeletal muscle mass affects the incidence of minimal hepatic encephalopathy:a case control study.BMC Gastroenterol,2020,20(1):371.
[15] Maharshi S,Sharma BC,Sachdeva S,et al.Efficacy of nutritional therapy for patients with cirrhosis and minimal hepatic encephalopathy in a randomized trial.Clin Gastroenterol Hepatol,2016,14(3):454-460.
[16] Ooi Poh Hwa,Hager Amber,Mazurak Vera C,et al.Sarcopenia in chronic liver disease:impact on outcomes.Liver Transpl,2019,25(9):1422-1438.
[17] Wijarnpreecha K, Werlang M, Panjawatanan P, et al. Association between sarcopenia and hepatic encephalopathy:A systematic review and meta-analysis.Ann Hepatol,2020,19(3):245-250.
[18] Ebadi M,Montano-loza AJ. Sarcopenia and frailty in the prognosis of patients on the liver transplant waiting list. Liver Transpl,2019,25(1):7-9.
[19] Plauth M,Bernal W,Dasarathy S,et al. ESPEN guideline on clinical nutrition in liver disease.Clin Nutr,2019,38(2):485-521.
[20] 张帮婷,胥莹,杨雪芳,等. 肝硬化肌少症与经颈静脉肝内门体分流术预后的关系.临床肝胆病杂志,2021,37(12):2932-2934.
[21] Praktiknjo M,Book M,Lutkens J,et al. Fat-free muscle mass in magnetic resonance imaging predicts acute-on-chronic liver failure and survival in decompensated cirrhosis.Hepatology,2018,67(3):1014-1026.
[22] 周达,王新颖.肝移植围术期肌少症的研究进展.中华临床营养杂志,2021,29(3):180-185.
[23] Wackenthaler A,Molière S,Artzner T,et al. Pre-operative CT scan helps predict outcome after liver transplantation for acute-on-chronic grade 3 liver failure.Eur Radiol,2022,32(1):12-21.
[24] 孙超,侯莉明,简伟明,等.我国60岁以上老年人群肌少症患病率及相关因素调查.中华老年医学杂志,2021,40(8):981-986.
[25] Nardelli S,Lattanzi B,Torrisi S,et al.Sarcopenia is risk factor for development of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt placement.Clin Gastroenterol Hepatol,2017,15(6):934-936.
[26] Dasarathy S,Merli M.Sarcopenia from mechanism to diagnosis and treatment in liver disease.J Hepatol,2016,65(6):1232-1244.
[27] Rombouts K,Bémeur C,Rose CF.Targeting the muscle for the treatment and prevention of hepatic7encephalopathy.J Hepatol,2016,65(5):876-878.
[28] 梁计陵,王岑依,司誉豪,等. 肌少症的运动康复机制研究进展.中华物理医学与康复杂志,2021,43(9):848-852.
[29] 周韩,邓奕辉,马钟丹妮,等.马培之辨治痿证的学术思想及临床经验.中医药学报,2019,47(1):113-116.
[30] 王琴,张彬,林萍,等. 参苓白术散治疗肌少症患者的临床疗效观察.中华危重病急救医学,2021,33(8):994-998.
[31] 何松,苏悦,常永龙,等.王清任《医林改错》活血化瘀思想探骊.福建中医药,2019,50(04):46-47. |
